Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Contract

14 Jul 2023 07:00

RNS Number : 9567F
Galliford Try Holdings PLC
14 July 2023
 

GALLIFORD TRY APPOINTED TO £72M REMODELLING OF LANDMARK LONDON OFFICE

Galliford Try, one of the UK's leading construction groups, announces that its Building business has been appointed by St Martin's Property Investments Limited to undertake the £72m remodelling and refurbishment of Adelaide House in central London.

 

The works consist of the remodelling of the nine-storey, Grade II-listed building, adjacent to London Bridge to a Category A office standard, as well as reconfiguration and enhancement works to external areas including the roof and riverside gardens.

 

Bill Hocking, Chief Executive of Galliford Try, commented: "We are delighted to be working with St Martin's on this landmark building with a prestigious location on the banks of the Thames. Our Building team has a proud record of delivering high-quality, sustainable office spaces within the capital."

 

 

Galliford Try

 

Bill Hocking, Chief Executive 01895 855001

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

 

Notes to Editors 

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

For more information on the building please see https://adelaidehouse.london/. CBRE and Savills are the leasing agents.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTZZGMNGFMGFZM
Date   Source Headline
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:02 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTrading Statement
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 202512:01 pmRNSContract
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 202510:04 amRNSTotal Voting Rights
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20247:05 amRNSContract
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 202411:45 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSTransaction in Own Shares
28th Nov 20243:00 pmRNSResult of AGM
28th Nov 20247:00 amRNSAGM Statement
20th Nov 202410:00 amRNSDirectorate Change
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20248:00 amRNSTotal Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 202412:10 pmRNSDirector/PDMR Shareholding
28th Oct 202411:00 amRNSDirector/PDMR Shareholding
28th Oct 20249:30 amRNSDirector/PDMR Shareholding
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.